Clavejo, Meriam A.
HRN: 22-00-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2022
AMPICILLIN 500MG (VIAL)
09/27/2022
10/04/2022
IV
2gm
Q6
PROM X 24 Hours
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes